Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals Inc.
WKN: A1W2RM / Symbol: AGIO / Name: Agios / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
26,60 €
-0,76 %
Agios Pharmaceuticals (AGIO) had its price target raised by HC Wainwright from $52.00 to $55.00. They now have a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals (AGIO) had its price target lowered by Truist Financial Corporation from $41.00 to $39.00. They now have a "buy" rating on the stock.
Ratings data for AGIO provided by MarketBeat


Neueste Beiträge
Canaccord_Genuity_Gr in Neurocrine Bioscience diskutieren